Lactose Intolerance at IBS

by palligoelme@gmail.com | Apr 17, 2025 | Clinical Trials

​ Conditions: Lactose Intolerance Sponsors: Assiut University Not yet recruiting Conditions: Lactose Intolerance Sponsors: Assiut University Not yet recruiting 

Non-interventional Study to Assess the Effectiveness and Safety of Ribociclib in the Adjuvant Therapy of Hormone Receptor Positive (HR+) HER2-negative Stage II and III Breast Cancer in Real Clinical Practice in Russia

by palligoelme@gmail.com | Apr 16, 2025 | Clinical Trials

​ Conditions: Breast Cancer Interventions: Drug: Ribociclib; Drug: Letrozole; Drug: Anastrozole Sponsors: Novartis Pharmaceuticals Not yet recruiting Conditions: Breast Cancer Interventions: Drug: Ribociclib; Drug: Letrozole; Drug: Anastrozole Sponsors: Novartis...

Post-Market Evaluation of Active Thrombectomy and Proximal Aspiration During Lower Extremity Tibial Interventions

by palligoelme@gmail.com | Apr 16, 2025 | Clinical Trials

​ Conditions: Peripheral Arterial Disease Sponsors: Protexa Endovascular, Inc. Not yet recruiting Conditions: Peripheral Arterial Disease Sponsors: Protexa Endovascular, Inc. Not yet recruiting 

Dexamethasone for Ureteral STent Symptoms (DUSTS)

by palligoelme@gmail.com | Apr 16, 2025 | Clinical Trials

​ Conditions: Ureteral Stent-Related Symptom Interventions: Drug: Dexamethasone Sodium Phosphate Injection Sponsors: The Methodist Hospital Research Institute Not yet recruiting Conditions: Ureteral Stent-Related Symptom Interventions: Drug: Dexamethasone Sodium...

A Phase Ib/II Clinical Trial of Multiple Doses of STSA-1301 Subcutaneous Injection in Healthy Subjects and Patients With Immune Thrombocytopenia (ITP)

by palligoelme@gmail.com | Apr 16, 2025 | Clinical Trials

​ Conditions: Primary Immune Thrombocytopenia (ITP) Interventions: Drug: STSA-1301 subcutaneous injection; Drug: Placebo Sponsors: Jiangsu BioJeTay Biotechnology Co., Ltd. Not yet recruiting Conditions: Primary Immune Thrombocytopenia (ITP) Interventions: Drug:...